Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Subjects”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01708590
What this trial is testing

Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab in Moderate to Severe Plaque Psoriasis Subjects

Who this might be right for
Psoriasis
Bausch Health Americas, Inc. 661
Early research (Phase 1)Study completedNCT00382512
What this trial is testing

Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Genentech, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Post-approval studies (Phase 4)Study completedNCT02690701
What this trial is testing

Study to Evaluate the Effect of Secukinumab Compared to Placebo on Aortic Vascular Inflammation in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 91
Testing effectiveness (Phase 2)Study completedNCT00796211
What this trial is testing

A Single-Center Exploratory Study to Assess the Activity of CRx-197-002 in Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Zalicus 20
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Large-scale testing (Phase 3)Study completedNCT00141921
What this trial is testing

Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

Who this might be right for
Pediatric Plaque Psoriasis
Amgen 182
Testing effectiveness (Phase 2)Study completedNCT03638258
What this trial is testing

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Arcutis Biotherapeutics, Inc. 331
Post-approval studies (Phase 4)Study completedNCT00932113
What this trial is testing

Mechanism of Action Study for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 33
Large-scale testing (Phase 3)Study completedNCT07357831
What this trial is testing

A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects

Who this might be right for
Plaque Psoriasis
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 539
Large-scale testing (Phase 3)Study completedNCT00267969
What this trial is testing

Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 766
Testing effectiveness (Phase 2)Study completedNCT03442088
What this trial is testing

Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

Who this might be right for
Plaque Psoriasis
University Hospitals Cleveland Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT02776033
What this trial is testing

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis

Who this might be right for
Psoriasis
GlaxoSmithKline 65
Large-scale testing (Phase 3)Ended earlyNCT04305327
What this trial is testing

Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 12
Post-approval studies (Phase 4)Study completedNCT02125279
What this trial is testing

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
Galderma R&D 54
Large-scale testing (Phase 3)Study completedNCT02325219
What this trial is testing

An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 192
Large-scale testing (Phase 3)Study completedNCT01235442
What this trial is testing

Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 592
Early research (Phase 1)Study completedNCT06738277
What this trial is testing

This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 186
Large-scale testing (Phase 3)Study completedNCT01177800
What this trial is testing

Evaluate Safety and Efficacy of Infliximab in Chinese Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Xian-Janssen Pharmaceutical Ltd. 129
Post-approval studies (Phase 4)Study completedNCT05969223
What this trial is testing

Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis

Who this might be right for
Genital PsoriasisScalp Psoriasis
AbbVie 214
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation